This symposium brought together leaders in cancer care, research, policy and consumer advocacy to advance the integration of genomics into cancer care. Focused on collaboration, equity and implementation, it reviewed progress against the National Framework for Genomics in Cancer Control, showcased best-practice models, and identified opportunities to strengthen patient pathways and improve access to genomic services.
Through knowledge sharing and partnership building, the symposium aimed to equip the cancer workforce and lived experience advocates with the confidence and skills to embed genomics in oncology practice and accelerate better outcomes for all Australians.
Watch on demand
Symposium recording
The recording is published as seven sessions. Select a session to expand it and watch.
01 Welcome and opening 9 min
Professor David Ashley and Dr Kortnye Smith open From Roadmap to Realisation, outlining the urgent need to implement cancer genomics and precision medicine across Australia. They introduce the forum's focus on equitable access, stronger patient pathways, coordinated investment and improved cancer outcomes.
02 Integrating genomics into cancer care 1 hr 27 min
This session brings together lived-experience, policy, clinical and research perspectives on integrating genomics into cancer care across Australia. Speakers examine consumer awareness and access to tumour genomic profiling, national policy and implementation initiatives, Omico's work to expand equitable access to precision oncology, and the clinical potential of whole-genome sequencing and liquid biopsy.
03 Strengthening patient pathways 26 min
In Strengthening Patient Pathways, the session examines clinician- and patient-level barriers to effectively integrating genomic testing into cancer care, including gaps in clinician knowledge and confidence, complex consent discussions, inconsistent reporting and patients' limited understanding of results. It explores practical responses including ongoing case-based education, co-designed decision-support resources, molecular tumour boards, clearer communication, and careful management of germline findings and genomic data.
04 Equity in genomics: regional and rural access 52 min
Focused on equity in genomics, this session examines access to genomic profiling and precision oncology for people living in regional and rural Australia. It combines Omico data, Amelia James's lived experience of genomics-informed treatment, and clinical perspectives on overcoming barriers to matched therapies through local champions, decentralised trials and collaborative trial networks.
05 Equity in genomics: Aboriginal and Torres Strait Islander communities 22 min
This session looks at understanding and addressing equity in genomics, including current barriers and opportunities for Aboriginal and Torres Strait Islander people. It covers underrepresentation in cancer clinical trials, financial toxicity, clinician bias, endemic racism in health and research systems, cultural safety, Indigenous data sovereignty, and culturally informed practices, governance and research.
06 Accelerating precision oncology through technology 42 min
This session discusses accelerating precision oncology through technology, focusing on the implementation gap, sustainable and adequate funding, data connectivity, workforce education, equitable access and the use of artificial intelligence to support decision-making at scale.
07 Closing statements 2 min
Closing reflections on the need to work as a team to move genomics forward, followed by thanks to everyone who contributed to the symposium.
At a glance
The symposium in brief
Originally held
Friday 7 August 2026, 9.00am–3.45pm AEST
Lecture Theatre B, Peter MacCallum Cancer Centre, and online.
Who this is for
Healthcare professionals and leaders in cancer care
Healthcare professionals and leaders in cancer care, research, policy, and consumer advocacy.
Objectives
— Unite leaders in cancer care, research, policy, and consumer advocacy
— Review progress and align initiatives with the National Framework for Genomics in Cancer Control
— Strengthen patient pathways and addressing equity for all populations
— Equip clinicians with the knowledge and skills to confidently integrate genomics into oncology practice
Outcomes
— Share priorities identified to accelerate implementation of the Roadmap to Precision Oncology in line with the National Framework for Genomics in Cancer Control
— Best-practice models showcased to strengthen coordination and patient pathways
— Barriers and opportunities identified to improve genomic access for Aboriginal and Torres Strait Islander peoples, rural, and regional communities
— Stronger national partnerships established to drive continuous improvement and knowledge exchange
Contributors
Convenor and speakers
Convenor
Dr Kortnye Smith
Medical oncologist and researcher, Peter MacCallum Cancer Centre and Eastern Health
After completing her medical oncology training, Dr Smith pursued a two-year fellowship at Peter MacCallum Cancer Centre and the Melbourne Genomic Health Alliance where she investigated genomic sequencing in cancer therapy. Kortnye works mainly in lung cancer and melanoma as well as focusing on her passion to improve patient equity by coordinating the Oncology in the Home program in Melbourne.
Speakers
Prof David Ashley
Chief Executive Officer VCCC Alliance, Laboratory Head, Walter and Eliza Hall Institute - The Brain Cancer Centre; Neuro-oncologist, Peter MacCallum Centre
Prof Vivienne Milch
Medical Director and Head, Clinical Policy Advice Branch, Cancer Australia
Kathy Minas
Lived experience leader and advocate
Tiffany Boughtwood
Australian Health Genomics Commissioner
Dr Damien Kee
Deputy Chair, Omico Molecular Oncology Board; Medical Oncologist, Austin Health and Peter MacCallum Cancer Centre; Research Fellow, Walter Eliza Hall Institute
Prof Sean Grimmond
Director, Collaborative Centre for Cancer Genomics, Centre for Cancer Research
A/Prof Alison Trainer
Peter MacCallum Cancer Centre
Louise Lyons
Senior Manager, Strategy and Policy, Australian Alliance for Indigenous Genomics; VCCC Alliance Aboriginal and Torres Strait Islander Health Research and Education Co-Lead
Melissa Sheldon
Lived experience leader and advocate
Leah Lindrea-Morrison
Lotjpa Yapaneyepuk – Talk Together
Dr Samuel Harris
Medical Oncologist, Bendigo Regional Cancer Centre, Bendigo Health; Regional and Rural Research and Education Lead, VCCC Alliance
Amelia James
Lived experience leader and advocate
Dr Malaka Ameratunga
Medical Oncologist, Bayside Health, MPCCC
Endorsed by

Partners

AstraZeneca and Moderna provided financial support for this event. Content was developed independently by the VCCC Alliance and the presenting faculty.
Resource details
This course is brought to you by
